Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-10-28
DOI
10.1093/ecco-jcc/jjx145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohnʼs Disease
- (2017) Takeo Yoshihara et al. INFLAMMATORY BOWEL DISEASES
- Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn’s Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study
- (2017) William J. Sandborn et al. Journal of Crohns & Colitis
- A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines
- (2017) Qihong Zhao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
- (2017) Deepak A. Rao et al. NATURE
- A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15
- (2017) Borja Ocón et al. Frontiers in Immunology
- CitH3: a reliable blood biomarker for diagnosis and treatment of endotoxic shock
- (2017) Baihong Pan et al. Scientific Reports
- Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease
- (2016) G. Monteleone et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chemokine and cytokine levels in inflammatory bowel disease patients
- (2016) Udai P. Singh et al. CYTOKINE
- Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
- (2016) Aida Kapic Lunder et al. GASTROENTEROLOGY
- Leukocyte Trafficking to the Small Intestine and Colon
- (2016) Aida Habtezion et al. GASTROENTEROLOGY
- Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity
- (2016) Palak J. Trivedi et al. JOURNAL OF AUTOIMMUNITY
- Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells
- (2016) Emily Wendt et al. JOURNAL OF IMMUNOLOGY
- Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance
- (2016) Neeraja Kulkarni et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease
- (2016) S. Barret Kalindjian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease
- (2015) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Targeting chemokines: Pathogens can, why can’t we?
- (2015) Amanda E.I. Proudfoot et al. CYTOKINE
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
- (2015) William J. Sandborn et al. Journal of Crohns & Colitis
- CCR9 Antagonists in the Treatment of Ulcerative Colitis
- (2015) Pirow Bekker et al. MEDIATORS OF INFLAMMATION
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
- (2015) Jimmy Z Liu et al. NATURE GENETICS
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
- (2015) Giovanni Monteleone et al. NEW ENGLAND JOURNAL OF MEDICINE
- The microbiota regulates type 2 immunity through ROR t+ T cells
- (2015) C. Ohnmacht et al. SCIENCE
- Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells
- (2015) Helene Kolstad Skovdahl et al. PLoS One
- The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
- (2014) S T Ward et al. BRITISH JOURNAL OF CANCER
- T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
- (2014) Mahmoud H. Mosli et al. DRUGS
- CCL25/CCR9 Interactions Are Not Essential for Colitis Development but Are Required for Innate Immune Cell Protection from Chronic Experimental Murine Colitis
- (2014) Marc-André Wurbel et al. INFLAMMATORY BOWEL DISEASES
- Chemokine Cooperativity Is Caused by Competitive Glycosaminoglycan Binding
- (2014) F. Verkaar et al. JOURNAL OF IMMUNOLOGY
- Role and species-specific expression of colon T cell homing receptor GPR15 in colitis
- (2014) Linh P Nguyen et al. NATURE IMMUNOLOGY
- CCL25/CCR9 Interactions Regulate the Function of iNKT Cells in Oxazolone-Induced Colitis in Mice
- (2014) Siying Zhu et al. PLoS One
- The Role of CXCR3 in DSS-Induced Colitis
- (2014) Belal Chami et al. PLoS One
- Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis
- (2013) Michael Eberhardson et al. CLINICAL IMMUNOLOGY
- Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
- (2013) Lloyd Mayer et al. GUT
- Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
- (2013) Laurent Peyrin-Biroulet et al. GUT
- Mucosal immunity in liver autoimmunity: A comprehensive review
- (2013) Palak J. Trivedi et al. JOURNAL OF AUTOIMMUNITY
- TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica
- (2013) Y Sugiura et al. Mucosal Immunology
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
- (2013) Satish Keshav et al. PLoS One
- Whole Genome Gene Expression Meta-Analysis of Inflammatory Bowel Disease Colon Mucosa Demonstrates Lack of Major Differences between Crohn's Disease and Ulcerative Colitis
- (2013) Atle van Beelen Granlund et al. PLoS One
- GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa
- (2013) S. V. Kim et al. SCIENCE
- A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease
- (2012) F. Zorzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease
- (2012) E. R. Mann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CCL25 induces α4β7integrin-dependent migration of IL-17+γδ T lymphocytes during an allergic reaction
- (2012) Maria F. S. Costa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central Tolerance
- (2012) Husein Hadeiba et al. IMMUNITY
- CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice
- (2012) Shinta Mizuno et al. IMMUNOLOGY LETTERS
- Enhanced Expression of CXCL10 in Inflammatory Bowel Disease
- (2012) Ann E. Østvik et al. INFLAMMATORY BOWEL DISEASES
- Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
- (2012) Huanhuan Joyce Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
- (2012) Giovanni Monteleone et al. MOLECULAR THERAPY
- HLA-DRhi and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD
- (2012) Ludvig Linton et al. Clinical and Translational Gastroenterology
- Smad7 Expression in T cells Prevents Colitis-Associated Cancer
- (2011) A. Rizzo et al. CANCER RESEARCH
- The Chemokine Receptor CCR9 Is Required for the T-Cell–Mediated Regulation of Chronic Ileitis in Mice
- (2011) Joshua D. Wermers et al. GASTROENTEROLOGY
- CCL17 Promotes Intestinal Inflammation in Mice and Counteracts Regulatory T Cell–Mediated Protection From Colitis
- (2011) Alexander F. Heiseke et al. GASTROENTEROLOGY
- Control of TH17 cells occurs in the small intestine
- (2011) Enric Esplugues et al. NATURE
- CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis
- (2011) Marc-Andre Wurbel et al. PLoS One
- Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
- (2010) M. J. Walters et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Epithelial decision makers: in search of the 'epimmunome'
- (2010) Mahima Swamy et al. NATURE IMMUNOLOGY
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- CCL25 and CCL28 promote α4β7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow
- (2008) Alice Miles et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Role of β7 Integrin and the Chemokine/Chemokine Receptor Pair CCL25/CCR9 in Modeled TNF-Dependent Crohn's Disease
- (2008) Maria Apostolaki et al. GASTROENTEROLOGY
- Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
- (2008) Massimo C. Fantini et al. GASTROENTEROLOGY
- Lymphocyte homing and its role in the pathogenesis of IBD
- (2008) Bertus Eksteen et al. INFLAMMATORY BOWEL DISEASES
- CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease
- (2008) Husein Hadeiba et al. NATURE IMMUNOLOGY
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now